Deke Cateau is CEO of A.G. Rhodes. Caring is part of his DNA.
Straight from the gut: AI helps researchers confirm Alzheimer’s link
By
John O'Connor
Apr 24, 2024
Cleveland Clinic researchers are using artificial intelligence to confirm the link between the gut microbiome and Alzheimer’s disease.
Silverado first US organization to receive Alzheimer’s Disease International accreditation
By
Kathleen Steele Gaivin
Apr 24, 2024
Irvine, CA-based Silverado has become the first US-based organization to earn accreditation from Alzheimer’s Disease International after becoming the first care provider anywhere to receive the accreditation...
American Academy of Neurology, April 13-18
Apr 23, 2024
The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including clinicians, academicians, allied health professionals,...
Assisted living providers can take steps to address workforce shortages, quality, Alzheimer’s Association...
By
Lois A. Bowers
Apr 22, 2024
As federal lawmakers ponder ways to address workforce shortages and quality in senior living communities and other long-term care settings, the Alzheimer’s Association and its advocacy affiliate, the...
LCS Foundation raises $300,000 for Alzheimer’s, scholarships, more
By
Kathleen Steele Gaivin
Apr 22, 2024
The Des Moines, IA-based LCS Foundation raised more than $300,000 last year from 523 donors to support efforts that advance Alzheimer’s care and research as well as collegiate partnerships and scholarships,...
Risk for adverse outcomes increased with antipsychotic use in dementia
Apr 19, 2024
Risks increased for stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia and acute kidney injury.
Using AI to fill senior living staffing gaps
By
Honghao Deng
Apr 18, 2024
Recent advances in artificial intelligence, or AI, offer a way to help prevent lonely deaths and proactively identify potential long-term issues.
Lower risk for MCI, dementia seen with cognitively stimulating occupations
Apr 17, 2024
Participants in a high versus low routine task intensity group had a higher risk for mild cognitive impairment and dementia.
Apple Watch’s ‘Foggy’ gets FDA medical device listing for Parkinson’s
By
John O'Connor
Apr 16, 2024
A new Apple Watch-enabled freezing of gait-cueing feature, dubbed Foggy, has received FDA listing as a Class II medical device and is available via prescription.
